Pillstats
OTC · Syrup · Oral

Guaifenesin And Dextromethorphan Hydrobromide

Dextromethorphan Hydrobromide + Guaifenesin

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US3 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCR05DA09
RxCUI (US)3289
US makers2 labelers
Packages3
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.007$0.014$0.022$0.029Jan 2026Mar 2026Apr 2026
$0.025
Latest avg · Apr 22, 2026
+3%
Since Jan 21, 2026
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

15K29K44K58K2025 Q12025 Q22025 Q32025 Q42026 Q1
51K
Rx · 2026 Q1
10.5M
Units dispensed
+30%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Method Pharmaceuticals, LLCunknown2SUPPLYING
Bryant Ranch Prepackrepackager1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.